News

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Eli Lilly’s Zepbound shows superior weight loss over Novo Nordisk's Wegovy in trial
Eli Lilly (NYSE:LLY) on Sunday said that its drug Zepbound (tirzepatide) showed superior weight loss over Novo Nordisk's (NVO ...
TipRanks on MSN3d
Eli Lilly’s Zepbound Defeats Novo Nordisk’s Wegovy Once Again
Preview in new tab Pharmaceutical giants Eli Lilly ($LLY) and Novo Nordisk ($NVO) are engaged in a head-to-head battle to ...
New York Post2d
This drug led to 50% more weight loss than Wegovy in head-to-head study
Published in the New England Journal of Medicine, the study followed 751 obese Americans to test the efficacy ... of either Zepbound, Eli Lilly’s obesity drug, or Novo Nordisk’s Wegovy.
EconoTimes3d
Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Head-to-Head Trial
Eli Lilly announced that its obesity drug Zepbound outperformed Novo Nordisks Wegovy in a direct comparison across five key ...
ABC News4d
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
While tirzepatide won out in what Aronne said many view as “a drag race of efficacy ... tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or ...
The Columbian3d
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Boxes for the medications Wegovy and Zepbound are arranged for a photograph ... out in what Aronne said many view as “a drag race of efficacy,” both are important tools for treating obesity ...